Chase v. Janssen Pharmaceuticals
Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF INDIANA SOUTH BEND DIVISION
CHRISTIAN CHASE, ) Plaintiff, ) ) v. ) CAUSE NO.: 3:23-CV-919-JVB-JEM ) JANSSEN PHARMACEUTICALS, ) Defendant. )
OPINION AND ORDER Christian Chase, a prisoner without a lawyer, filed a complaint against Janssen Pharmaceuticals, asserting a state-law claim of products liability based on alleged side effects from a medication he took between 1998 and 2006. (ECF 1). He did not allege a basis for subject matter jurisdiction to allow this state-law claim to be heard in federal court, so he was given the opportunity to file an amended complaint. (ECF 2). He was told that diversity jurisdiction requires the plaintiff to be a citizen of a different state than the defendant and the amount in controversy to exceed $75,000. See 28 U.S.C. § 1332. His original complaint did not allege either party’s citizenship or allege the amount of damages he was seeking. Without this information, this Court cannot hear a case based only on a state-law claim. See Page v. Democratic Nat’l Comm., 2 F.4th 630 (7th Cir. 2021). Chase filed an amended complaint. (ECF 6). In the amended complaint, he asks for $4,500,000 in damages for pain and suffering. Id. at 4. But he provides no new information about the parties’ citizenship as instructed. Without this information, Chase has not established a plausible basis for this court to exercise subject matter jurisdiction over this case. This case must be dismissed. See Miller v. Sw. Airlines Co., 926 F.3d 898, 902 (7th Cir. 2019) (“Subject-matter jurisdiction is the first issue in any case[.]”). “The usual standard in civil cases is to allow defective pleadings to be corrected, especially in early stages, at least where amendment would not be futile.” Abu-Shawish v. United States, 898 F.3d 726, 738 (7th Cir. 2018). However, “courts have broad discretion to deny leave to amend where . . . the amendment would be futile.” Hukic v. Aurora Loan Servs., 588 F.3d 420, 432 (7th
Cir. 2009). There is no indication that, if given another chance, Chase would be able to satisfy the requirements of diversity jurisdiction. For these reasons, this case is DISMISSED without prejudice for a lack of subject matter jurisdiction. SO ORDERED on April 9, 2024. s/ Joseph S. Van Bokkelen JOSEPH S. VAN BOKKELEN, JUDGE UNITED STATES DISTRICT COURT
Free access — add to your briefcase to read the full text and ask questions with AI
Chase v. Janssen Pharmaceuticals (Chase v. Janssen Pharmaceuticals) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.